Up-front Hematopoietic Stem Cell Transplantation in Acute Myeloid Leukemia Patients Aged 65-75
Up-front Hematopoietic Stem Cell Transplantation in Patients With Acute Myeloid Leukemia Aged 65-75
Sponsor: Associazione Italiana per la Ricerca sul Cancro
A PHASE2 clinical study on Acute Myeloid Leukemia, Adult, this trial is completed. The trial is conducted by Associazione Italiana per la Ricerca sul Cancro and has accumulated 7 data snapshots since 2019. Oncology trials at this stage typically focus on safety, tolerability, and early efficacy signals.
Status Flow
Change History
7 versions recorded-
Sep 2024 — Present [monthly]
Completed PHASE2
-
Aug 2024 — Sep 2024 [monthly]
Completed PHASE2
Status: Unknown → Completed
-
Jul 2024 — Aug 2024 [monthly]
Unknown PHASE2
Status: Unknown Status → Unknown
-
Oct 2021 — Jul 2024 [monthly]
Unknown Status PHASE2
Status: Enrolling By Invitation → Unknown Status
-
Jan 2021 — Oct 2021 [monthly]
Enrolling By Invitation PHASE2
▶ Show 2 earlier versions
-
Jul 2019 — Jan 2021 [monthly]
Enrolling By Invitation PHASE2
-
May 2019 — Jul 2019 [monthly]
Enrolling By Invitation PHASE2
First recorded
Mar 2019
Trial started
Per CT.gov start date — pre-dates our first snapshot
Eligibility Summary
No eligibility information available.
Contact Information
- Associazione Italiana per la Ricerca sul Cancro
- Fondazione Policlinico Universitario Agostino Gemelli IRCCS
For direct contact, visit the study record on ClinicalTrials.gov .